Skip to content

Clinical trials

Observational Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Observational Country / region: Italy Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20094
20132
20161
20181
20194
20203
20212
20225
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status11
Recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS Burlo Garofolo3
Amgen2
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Gruppo Italiano Malattie EMatologiche dell'Adulto2
IRCCS SYNLAB SDN2
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Azienda Ospedaliero-Universitaria di Parma1
Bambino Gesù Hospital and Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma27
Lymphoma, Large B-Cell, Diffuse3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma3
Burkitt Lymphoma2
Infections2
Invasive Fungal Infections2
Bacterial Infections1
Blast Crisis1
Breast Carcinoma In Situ1
Breast Neoplasms1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.